{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:41:10Z","timestamp":1772199670561,"version":"3.50.1"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168958","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T16:47:14Z","timestamp":1483980434000},"page":"e0168958","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis"],"prefix":"10.1371","volume":"11","author":[{"given":"Jun Won","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Mi","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ja-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-8627","authenticated-orcid":true,"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/ard.2009.124206","article-title":"Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis","volume":"69","author":"P Machado","year":"2010","journal-title":"Annals of the rheumatic diseases"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/ard.2011.150037","article-title":"A stratified model for health outcomes in ankylosing spondylitis","volume":"70","author":"P Machado","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/ard.2008.091793","article-title":"Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine","volume":"68","author":"R Landewe","year":"2009","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"J Braun","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","article-title":"Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study","volume":"54","author":"J Braun","year":"2006","journal-title":"Arthritis and rheumatism"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis","volume":"58","author":"D van der Heijde","year":"2008","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"D van der Heijde","year":"2008","journal-title":"Arthritis and rheumatism"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","article-title":"Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years","volume":"11","author":"D van der Heijde","year":"2009","journal-title":"Arthritis research & therapy"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2012-202698","article-title":"Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis","volume":"73","author":"X Baraliakos","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis","volume":"65","author":"N Haroon","year":"2013","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.18553\/jmcp.2013.19.8.621","article-title":"Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population","volume":"19","author":"VF Schabert","year":"2013","journal-title":"Journal of managed care pharmacy: JMCP"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/rheumatology\/kem133","article-title":"The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK","volume":"46","author":"RM Ara","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1136\/annrheumdis-2013-203407","article-title":"Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study","volume":"73","author":"JW Baddley","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/annrheumdis-2014-205202","article-title":"A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study","volume":"75","author":"J Zavada","year":"2016","journal-title":"Annals of the rheumatic diseases"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3899\/jrheum.111337","article-title":"Dosage adjustment of anti-tumor necrosis factor-alpha inhibitor in ankylosing spondylitis is effective in maintaining remission in clinical practice","volume":"39","author":"J Paccou","year":"2012","journal-title":"The Journal of rheumatology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ard.2003.018457","article-title":"Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change","volume":"64","author":"K Bruynesteyn","year":"2005","journal-title":"Annals of the rheumatic diseases"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"S van der Linden","year":"1984","journal-title":"Arthritis and rheumatism"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"D van der Heijde","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10067-011-1722-5","article-title":"Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease","volume":"30","author":"V Navarro-Compan","year":"2011","journal-title":"Clinical rheumatology"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2010.133488","article-title":"ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials\/epidemiological studies in axial spondyloarthritis","volume":"70","author":"M Dougados","year":"2011","journal-title":"Annals of the rheumatic diseases"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2011-201252","article-title":"Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"71","author":"D Poddubnyy","year":"2012","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"64","author":"MC Creemers","year":"2005","journal-title":"Annals of the rheumatic diseases"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/ard.2004.022038","article-title":"Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order","volume":"63","author":"A Wanders","year":"2004","journal-title":"Annals of the rheumatic diseases"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/0163278709338554","article-title":"Analyzing longitudinal data with the linear mixed models procedure in SPSS","volume":"32","author":"BT West","year":"2009","journal-title":"Evaluation & the health professions"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis","volume":"64","author":"D Poddubnyy","year":"2012","journal-title":"Arthritis and rheumatism"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"S Ramiro","year":"2014","journal-title":"Annals of the rheumatic diseases"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"e0122693","DOI":"10.1371\/journal.pone.0122693","article-title":"Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-alpha blocking therapy: a prospective longitudinal observational cohort study","volume":"10","author":"F Maas","year":"2015","journal-title":"PloS one"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/art.11017","article-title":"Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis","volume":"48","author":"J Brandt","year":"2003","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10067-007-0674-2","article-title":"Etanercept 25 mg\/week is effective enough to maintain remission for ankylosing spondylitis among Korean patients","volume":"27","author":"SH Lee","year":"2008","journal-title":"Clinical rheumatology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/annrheumdis-2013-204055","article-title":"Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study","volume":"74","author":"S Ramiro","year":"2015","journal-title":"Annals of the rheumatic diseases"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1002\/art.23044","article-title":"Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study","volume":"56","author":"RG Lambert","year":"2007","journal-title":"Arthritis and rheumatism"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/rheumatology\/kei046","article-title":"Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab","volume":"44","author":"J Sieper","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/art.20977","article-title":"Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept","volume":"52","author":"X Baraliakos","year":"2005","journal-title":"Arthritis and rheumatism"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/annrheumdis-2011-200859","article-title":"Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification","volume":"72","author":"WP Maksymowych","year":"2013","journal-title":"Annals of the rheumatic diseases"},{"key":"ref35","article-title":"MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis","author":"PM Machado","year":"2015","journal-title":"Annals of the rheumatic diseases"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"A Wanders","year":"2005","journal-title":"Arthritis and rheumatism"},{"key":"ref37","article-title":"Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)","author":"J Sieper","year":"2015","journal-title":"Annals of the rheumatic diseases"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1742-7843.2007.00149.x","article-title":"Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process","volume":"102","author":"K Vuolteenaho","year":"2008","journal-title":"Basic & clinical pharmacology & toxicology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T13:57:24Z","timestamp":1718978244000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168958"}},"subtitle":[],"editor":[{"given":"James T.","family":"Rosenbaum","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168958","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727151497.793550512","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}